Status: Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
Participants needed: 46
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: SciTech Development, Inc.Updated: Sep 22, 2025Locations: 10
Eligibility criteria
Cutaneous T-cell lymphoma (CTCL): mycosis fungoides (MF), Sézary Syndrome (SS),... [+21]
Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for n... [+11]